IMU has a good shot IF those patients who responded in the last announcement stay healthy and dont relapse AND especially if more patients respond with further treatment. Adding just a few months to a patients life, while important for the patient, probably wont result in a commercial deal.
We are well past the point where speculation about what this company COULD do is going to excite the market. Raw results is the only thing that will shift the SP and keep it there. And there is really no need to risk any cash until then. As with the last run which lasted 6 days, an entry anywhere with the momentum would have given a healthy profit.
Ann: Europe Patent to be Granted for PD1-Vaxx Cancer Vaccine, page-86
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.003(5.56%) |
Mkt cap ! $417.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.8¢ | 5.2¢ | $2.499M | 45.00M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1921794 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 1368288 | 7 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |